Newborn screening for cCMV infection appears to be cost-effective under a wide range of assumptions. Universal screening offers larger net savings and the greatest opportunity to provide directed care. Targeted screening also appears to be cost-effective and requires testing for fewer newborns. These findings suggest that implementation of newborn cCMV screening programs is warranted.
No takes yet. Share an insight, caveat, or question.
Gantt et al. (2016) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: